Tong-Yuan Yang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Computed Tomography

Diabetic Retinopathy

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer Lynn Ford, Eleni Karatza, Hardik Mody, Prathap Nagaraja Shastri, Sana Khajeh Pour, Tong-Yuan Yang, Michael Swanson, Daniel Chao, Damayanthi Devineni
Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene Therapy. Clinical pharmacology and therapeutics 115 (6) (2024)
Jennifer Lynn Ford, Eleni Karatza, Hardik Mody, Prathap Nagaraja Shastri, Sana Khajeh Pour, Tong-Yuan Yang, Michael Swanson, Daniel Chao, Damayanthi Devineni
Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene Therapy. Clinical pharmacology and therapeutics 115 (6) (2024)
Jennifer Lynn Ford, Eleni Karatza, Hardik Mody, Prathap Nagaraja Shastri, Sana Khajeh Pour, Tong-Yuan Yang, Michael Swanson, Daniel Chao, Damayanthi Devineni
Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene Therapy. Clinical pharmacology and therapeutics (2024)
Hardik Mody, Ken Ogasawara, Xu Zhu, Dale Miles, Prathap Nagaraja Shastri, Jochem Gokemeijer, Michael Z Liao, Sreeneeranj Kasichayanula, Tong-Yuan Yang, Nagendra Chemuturi, Swati Gupta, Vibha Jawa, Vijay V Upreti
Best Practices & Considerations for Clinical Pharmacology & Pharmacometric Aspects for Optimal Development of CAR-T & TCR-T Cell Therapies: An Industry Perspective. Clinical pharmacology and therapeutics (2023)
Jochem Gokemeijer, Nanda Balasubramanian, Ken Ogasawara, Joanna Grudzinska-Goebel, Vijay V Upreti, Hardik Mody, Siddha Kasar, Venkata R Vepachedu, Weifeng Xu, Swati Gupta, Edit Tarcsa, Robert Dodge, Kate Herr, Tong-Yuan Yang, Sophie Tourdot, Vibha Jawa
An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment aspects of CAR-T and TCR-T Cellular Therapies Development. Clinical pharmacology and therapeutics (2023)